Group 1 - The core point of the announcement is the election of the third board of directors for Tianchen International Medical Technology Co., Ltd., following the expiration of the second board's term [1][2]. - The board consists of 7 members, including 3 non-independent directors, 3 independent directors, and 1 employee representative director [2]. - The company held a meeting on December 22, 2025, to approve the election of candidates for the third board of directors [2][3]. Group 2 - The independent director candidates must be approved by the Shanghai Stock Exchange before being submitted for shareholder voting [3]. - The election will be conducted using a cumulative voting system during the first extraordinary general meeting of shareholders in 2026 [3][21]. - The new board will serve a term of three years starting from the date of approval by the shareholders [3]. Group 3 - The qualifications of the nominated directors meet the requirements set by relevant laws and regulations, and they do not fall under any disqualifying conditions [4]. - The current board has contributed positively to the company's operations and development during their tenure [4]. Group 4 - The announcement includes detailed resumes of the nominated candidates for both non-independent and independent director positions, highlighting their qualifications and experience [6][12][8][10][14][15]. - The candidates include individuals with significant experience in finance, management, and corporate governance, ensuring they are well-suited for their roles [6][12][8][10][14][15].
天臣国际医疗科技股份有限公司关于董事会换届选举的公告